

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 7.11312167 |
| 2 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 6.41209264 |
| 3 | pre-miRNA processing (GO:0031054) | 6.10216291 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.04672741 |
| 5 | hyperosmotic salinity response (GO:0042538) | 5.93153576 |
| 6 | layer formation in cerebral cortex (GO:0021819) | 5.81695489 |
| 7 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.58127057 |
| 8 | dendritic spine morphogenesis (GO:0060997) | 5.42051641 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 5.38296046 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.19879686 |
| 11 | nucleobase catabolic process (GO:0046113) | 5.19200751 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.18933888 |
| 13 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 5.08022900 |
| 14 | vocalization behavior (GO:0071625) | 5.05846538 |
| 15 | microtubule polymerization or depolymerization (GO:0031109) | 4.96049624 |
| 16 | regulation of response to osmotic stress (GO:0047484) | 4.86662468 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 4.86366804 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.86366804 |
| 19 | negative regulation of microtubule polymerization (GO:0031115) | 4.81413780 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.79096159 |
| 21 | neuron recognition (GO:0008038) | 4.75718847 |
| 22 | vascular smooth muscle contraction (GO:0014829) | 4.69386172 |
| 23 | presynaptic membrane assembly (GO:0097105) | 4.68169433 |
| 24 | neuronal action potential (GO:0019228) | 4.64122508 |
| 25 | proline transport (GO:0015824) | 4.59840337 |
| 26 | piRNA metabolic process (GO:0034587) | 4.46923286 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 4.46784003 |
| 28 | positive regulation of synapse assembly (GO:0051965) | 4.42282742 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.38029036 |
| 30 | tryptophan catabolic process (GO:0006569) | 4.33697085 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 4.33697085 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 4.33697085 |
| 33 | positive regulation of microtubule polymerization (GO:0031116) | 4.29304960 |
| 34 | regulation of energy homeostasis (GO:2000505) | 4.28542909 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27725333 |
| 36 | postsynaptic membrane organization (GO:0001941) | 4.26378004 |
| 37 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.26315022 |
| 38 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.19455242 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 4.18266885 |
| 40 | presynaptic membrane organization (GO:0097090) | 4.14911819 |
| 41 | calcium ion import (GO:0070509) | 4.14833078 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.12534459 |
| 43 | spinal cord motor neuron differentiation (GO:0021522) | 4.12420142 |
| 44 | membrane depolarization during action potential (GO:0086010) | 4.03694388 |
| 45 | response to dietary excess (GO:0002021) | 3.99354208 |
| 46 | histone mRNA catabolic process (GO:0071044) | 3.98166803 |
| 47 | protein localization to synapse (GO:0035418) | 3.97877909 |
| 48 | regulation of respiratory system process (GO:0044065) | 3.94531600 |
| 49 | axonal fasciculation (GO:0007413) | 3.91929717 |
| 50 | response to histamine (GO:0034776) | 3.91710645 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 3.88384166 |
| 52 | relaxation of smooth muscle (GO:0044557) | 3.88300839 |
| 53 | dopamine biosynthetic process (GO:0042416) | 3.87289465 |
| 54 | behavioral response to nicotine (GO:0035095) | 3.85608526 |
| 55 | glyoxylate metabolic process (GO:0046487) | 3.85313395 |
| 56 | hypotonic response (GO:0006971) | 3.84748016 |
| 57 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.84599311 |
| 58 | ncRNA catabolic process (GO:0034661) | 3.84073500 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.83365783 |
| 60 | protein insertion into membrane (GO:0051205) | 3.81666132 |
| 61 | cytoplasmic microtubule organization (GO:0031122) | 3.79986995 |
| 62 | dendrite morphogenesis (GO:0048813) | 3.79674390 |
| 63 | cell migration in hindbrain (GO:0021535) | 3.77438053 |
| 64 | regulation of timing of cell differentiation (GO:0048505) | 3.76642545 |
| 65 | establishment of integrated proviral latency (GO:0075713) | 3.73640202 |
| 66 | apical protein localization (GO:0045176) | 3.72054511 |
| 67 | organelle transport along microtubule (GO:0072384) | 3.68718094 |
| 68 | regulation of development, heterochronic (GO:0040034) | 3.68273958 |
| 69 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.67484006 |
| 70 | mating behavior (GO:0007617) | 3.66989873 |
| 71 | sodium ion export (GO:0071436) | 3.66185971 |
| 72 | gonadal mesoderm development (GO:0007506) | 3.65594053 |
| 73 | neuron remodeling (GO:0016322) | 3.64905038 |
| 74 | serotonin metabolic process (GO:0042428) | 3.62187470 |
| 75 | transmission of nerve impulse (GO:0019226) | 3.61070048 |
| 76 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.56309317 |
| 77 | mitochondrion transport along microtubule (GO:0047497) | 3.56309317 |
| 78 | inositol phosphate catabolic process (GO:0071545) | 3.54888767 |
| 79 | cornea development in camera-type eye (GO:0061303) | 3.54637891 |
| 80 | positive regulation of protein depolymerization (GO:1901881) | 3.53265266 |
| 81 | neural tube formation (GO:0001841) | 3.53169049 |
| 82 | regulation of translational fidelity (GO:0006450) | 3.46190190 |
| 83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.45482594 |
| 84 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.44532202 |
| 85 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44111748 |
| 86 | synaptic vesicle exocytosis (GO:0016079) | 3.42014373 |
| 87 | retina layer formation (GO:0010842) | 3.39342584 |
| 88 | asymmetric protein localization (GO:0008105) | 3.38923182 |
| 89 | lens morphogenesis in camera-type eye (GO:0002089) | 3.37889237 |
| 90 | synaptic transmission, glutamatergic (GO:0035249) | 3.37707876 |
| 91 | cerebral cortex neuron differentiation (GO:0021895) | 3.36382106 |
| 92 | cell differentiation in spinal cord (GO:0021515) | 3.35509445 |
| 93 | startle response (GO:0001964) | 3.35325239 |
| 94 | kynurenine metabolic process (GO:0070189) | 3.35158438 |
| 95 | serotonin receptor signaling pathway (GO:0007210) | 3.35041107 |
| 96 | post-embryonic morphogenesis (GO:0009886) | 3.33299427 |
| 97 | axon extension (GO:0048675) | 3.31390571 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.29720376 |
| 99 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29626822 |
| 100 | limb bud formation (GO:0060174) | 3.29087950 |
| 101 | neuronal stem cell maintenance (GO:0097150) | 3.26769011 |
| 102 | tryptophan metabolic process (GO:0006568) | 3.23615918 |
| 103 | neurotransmitter secretion (GO:0007269) | 3.22577014 |
| 104 | regulation of respiratory gaseous exchange (GO:0043576) | 3.22180607 |
| 105 | regulation of axon guidance (GO:1902667) | 3.21960078 |
| 106 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18483474 |
| 107 | cochlea development (GO:0090102) | 3.17225009 |
| 108 | regulation of synapse assembly (GO:0051963) | 3.16866864 |
| 109 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.16571808 |
| 110 | short-term memory (GO:0007614) | 3.15845839 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.12352535 |
| 112 | indole-containing compound metabolic process (GO:0042430) | 3.11842770 |
| 113 | neuron-neuron synaptic transmission (GO:0007270) | 3.10866052 |
| 114 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10647918 |
| 115 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.10191167 |
| 116 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.08110955 |
| 117 | kidney morphogenesis (GO:0060993) | 3.05678145 |
| 118 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.05239163 |
| 119 | neuron maturation (GO:0042551) | 3.04427223 |
| 120 | positive regulation of dendritic spine development (GO:0060999) | 3.04190369 |
| 121 | synapse assembly (GO:0007416) | 3.03853246 |
| 122 | neurotransmitter transport (GO:0006836) | 3.01058874 |
| 123 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.99683071 |
| 124 | regulation of filopodium assembly (GO:0051489) | 2.99238879 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.98321661 |
| 126 | establishment of planar polarity (GO:0001736) | 2.97993997 |
| 127 | establishment of tissue polarity (GO:0007164) | 2.97993997 |
| 128 | negative regulation of Notch signaling pathway (GO:0045746) | 2.97468839 |
| 129 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.97179999 |
| 130 | lymphoid progenitor cell differentiation (GO:0002320) | 2.96204447 |
| 131 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.94545754 |
| 132 | polyol catabolic process (GO:0046174) | 2.94315267 |
| 133 | prepulse inhibition (GO:0060134) | 2.93711822 |
| 134 | cellular sodium ion homeostasis (GO:0006883) | 2.93580398 |
| 135 | relaxation of cardiac muscle (GO:0055119) | 2.93455666 |
| 136 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.93369727 |
| 137 | sympathetic nervous system development (GO:0048485) | 2.93336438 |
| 138 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.92826000 |
| 139 | primary amino compound metabolic process (GO:1901160) | 2.92604279 |
| 140 | coenzyme A biosynthetic process (GO:0015937) | 2.91540624 |
| 141 | cell communication by electrical coupling (GO:0010644) | 2.90933870 |
| 142 | collecting duct development (GO:0072044) | 2.90384510 |
| 143 | establishment of viral latency (GO:0019043) | 2.88815106 |
| 144 | somatic stem cell maintenance (GO:0035019) | 2.88471785 |
| 145 | meiotic cell cycle (GO:0051321) | 2.88429437 |
| 146 | cell-cell junction maintenance (GO:0045217) | 2.88328490 |
| 147 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.88232740 |
| 148 | urinary tract smooth muscle contraction (GO:0014848) | 2.87966788 |
| 149 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.87917688 |
| 150 | action potential (GO:0001508) | 2.87428373 |
| 151 | microtubule nucleation (GO:0007020) | 2.87036984 |
| 152 | protein polyglutamylation (GO:0018095) | 2.86914405 |
| 153 | synaptic vesicle maturation (GO:0016188) | 2.85951897 |
| 154 | coenzyme A metabolic process (GO:0015936) | 2.85934891 |
| 155 | epithelial structure maintenance (GO:0010669) | 2.84787225 |
| 156 | maternal behavior (GO:0042711) | 2.82437677 |
| 157 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.82408318 |
| 158 | dendrite development (GO:0016358) | 2.81578460 |
| 159 | neuronal action potential propagation (GO:0019227) | 2.81263659 |
| 160 | glial cell proliferation (GO:0014009) | 2.80950156 |
| 161 | neurotransmitter uptake (GO:0001504) | 2.80763133 |
| 162 | indolalkylamine metabolic process (GO:0006586) | 2.80102423 |
| 163 | inner ear receptor stereocilium organization (GO:0060122) | 2.79614716 |
| 164 | regulation of synapse structural plasticity (GO:0051823) | 2.79508726 |
| 165 | adult feeding behavior (GO:0008343) | 2.79180411 |
| 166 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.77848867 |
| 167 | viral transcription (GO:0019083) | 2.77601680 |
| 168 | cardiovascular system development (GO:0072358) | 2.77566485 |
| 169 | respiratory electron transport chain (GO:0022904) | 2.76747789 |
| 170 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75596403 |
| 171 | positive regulation of action potential (GO:0045760) | 2.73713525 |
| 172 | thalamus development (GO:0021794) | 2.73470547 |
| 173 | forebrain neuron development (GO:0021884) | 2.73177506 |
| 174 | positive regulation of synapse maturation (GO:0090129) | 2.71862459 |
| 175 | electron transport chain (GO:0022900) | 2.71752968 |
| 176 | cell junction maintenance (GO:0034331) | 2.71569720 |
| 177 | synapse organization (GO:0050808) | 2.71121752 |
| 178 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.70916455 |
| 179 | retinal ganglion cell axon guidance (GO:0031290) | 2.70684283 |
| 180 | regulation of microtubule polymerization (GO:0031113) | 2.68878613 |
| 181 | regulation of glutamate secretion (GO:0014048) | 2.68484137 |
| 182 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.68392741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.73922388 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.88817282 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.74340441 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.52827109 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01005430 |
| 6 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.96921259 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77321391 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.73305345 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73296134 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.72112235 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60341406 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.60049624 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54457939 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54457939 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52711715 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48874536 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.43846423 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43193682 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40701805 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.31515794 |
| 21 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25097447 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16353982 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10210751 |
| 24 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08881094 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06452340 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.03723321 |
| 27 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.01107801 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96557844 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.94909527 |
| 30 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86682342 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77097579 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71017877 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66777886 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.65331517 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63327671 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.61265394 |
| 37 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.56837588 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.53467783 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.52976490 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51534959 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50386840 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49554290 |
| 43 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.49506972 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49171141 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48800347 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46994477 |
| 47 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.44950469 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38494741 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36937130 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36819252 |
| 51 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36140533 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35672863 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34223631 |
| 54 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32212978 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31871711 |
| 56 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29876862 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27793239 |
| 58 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.27526353 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25451427 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.25401953 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.25401953 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.25401953 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25298505 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24101400 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23486745 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22136280 |
| 67 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21692259 |
| 68 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21640270 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20457404 |
| 70 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20438295 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20322221 |
| 72 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.18152610 |
| 73 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17691477 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17042715 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17009855 |
| 76 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16857312 |
| 77 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16832545 |
| 78 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16832545 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16547561 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14981808 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13840825 |
| 82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12973536 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11739785 |
| 84 | * HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.11188895 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08927899 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08903688 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08878307 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08335123 |
| 89 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.06308724 |
| 90 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.05415215 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05229502 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04866594 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04399730 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03161460 |
| 95 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02846127 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01316086 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01053367 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00769884 |
| 99 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.00473033 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00021840 |
| 101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00021840 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99231036 |
| 103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99120209 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97354862 |
| 105 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97313130 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96342624 |
| 107 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96100166 |
| 108 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96042155 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95923742 |
| 110 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95460087 |
| 111 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95247065 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94355033 |
| 113 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.94325424 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94132298 |
| 115 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.94098466 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93967310 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93634752 |
| 118 | * JUN_21703547_ChIP-Seq_K562_Human | 0.91609153 |
| 119 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.88409701 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.87554219 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87508934 |
| 122 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87335999 |
| 123 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84192827 |
| 124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84192827 |
| 125 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83377729 |
| 126 | AR_19668381_ChIP-Seq_PC3_Human | 0.83253976 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82752090 |
| 128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79503955 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78898301 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78862749 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78735814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.68921973 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.69382778 |
| 3 | MP0005423_abnormal_somatic_nervous | 4.62846357 |
| 4 | MP0006276_abnormal_autonomic_nervous | 4.12992606 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.97931016 |
| 6 | MP0004133_heterotaxia | 3.52297280 |
| 7 | MP0008995_early_reproductive_senescence | 3.49117524 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.16069466 |
| 9 | MP0001984_abnormal_olfaction | 2.96857660 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.80293937 |
| 11 | MP0001188_hyperpigmentation | 2.79994024 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.73326951 |
| 13 | MP0009046_muscle_twitch | 2.61476439 |
| 14 | MP0009745_abnormal_behavioral_response | 2.58906463 |
| 15 | MP0000778_abnormal_nervous_system | 2.51263304 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.50108815 |
| 17 | MP0009278_abnormal_bone_marrow | 2.48193746 |
| 18 | MP0001486_abnormal_startle_reflex | 2.40521520 |
| 19 | MP0002064_seizures | 2.37270239 |
| 20 | MP0002184_abnormal_innervation | 2.36729626 |
| 21 | MP0002272_abnormal_nervous_system | 2.33782576 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.32915529 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.28622622 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.18199752 |
| 25 | MP0003122_maternal_imprinting | 2.15533059 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.05735476 |
| 27 | MP0004270_analgesia | 1.98678356 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.95335170 |
| 29 | MP0002102_abnormal_ear_morphology | 1.93097842 |
| 30 | MP0004142_abnormal_muscle_tone | 1.91226150 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.88411328 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.87798774 |
| 33 | MP0002736_abnormal_nociception_after | 1.77027326 |
| 34 | MP0005409_darkened_coat_color | 1.70903382 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.65516088 |
| 36 | MP0004742_abnormal_vestibular_system | 1.64646254 |
| 37 | MP0004147_increased_porphyrin_level | 1.64374232 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.63717992 |
| 39 | MP0001970_abnormal_pain_threshold | 1.63510862 |
| 40 | MP0001529_abnormal_vocalization | 1.60557969 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.60165741 |
| 42 | MP0004924_abnormal_behavior | 1.58778157 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.58778157 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.58295253 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.56365999 |
| 46 | MP0003879_abnormal_hair_cell | 1.48797948 |
| 47 | MP0005187_abnormal_penis_morphology | 1.45881608 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.38802925 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.34852759 |
| 50 | MP0002282_abnormal_trachea_morphology | 1.30758015 |
| 51 | MP0003890_abnormal_embryonic-extraembry | 1.29916282 |
| 52 | MP0003329_amyloid_beta_deposits | 1.29718941 |
| 53 | MP0001905_abnormal_dopamine_level | 1.29615081 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.27469764 |
| 55 | MP0002751_abnormal_autonomic_nervous | 1.23222954 |
| 56 | MP0003123_paternal_imprinting | 1.21906113 |
| 57 | MP0003942_abnormal_urinary_system | 1.19677388 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.18873726 |
| 59 | MP0002152_abnormal_brain_morphology | 1.18556806 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.16072290 |
| 61 | MP0000467_abnormal_esophagus_morphology | 1.15186923 |
| 62 | MP0003121_genomic_imprinting | 1.14583133 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.14330931 |
| 64 | MP0000955_abnormal_spinal_cord | 1.12678785 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 1.11169564 |
| 66 | MP0003724_increased_susceptibility_to | 1.10472584 |
| 67 | MP0000751_myopathy | 1.08468565 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.04318259 |
| 69 | MP0008775_abnormal_heart_ventricle | 1.03853042 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.02930487 |
| 71 | MP0003861_abnormal_nervous_system | 1.01438316 |
| 72 | MP0005394_taste/olfaction_phenotype | 1.00675973 |
| 73 | MP0005499_abnormal_olfactory_system | 1.00675973 |
| 74 | MP0000427_abnormal_hair_cycle | 1.00269129 |
| 75 | MP0008569_lethality_at_weaning | 0.98736186 |
| 76 | MP0004085_abnormal_heartbeat | 0.98242933 |
| 77 | MP0000026_abnormal_inner_ear | 0.98016115 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.96558006 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.96082688 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.94911527 |
| 81 | MP0003136_yellow_coat_color | 0.94179462 |
| 82 | MP0002752_abnormal_somatic_nervous | 0.93562061 |
| 83 | MP0006292_abnormal_olfactory_placode | 0.90225590 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.88997976 |
| 85 | MP0002229_neurodegeneration | 0.87990728 |
| 86 | MP0000647_abnormal_sebaceous_gland | 0.87444147 |
| 87 | MP0003315_abnormal_perineum_morphology | 0.86714894 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.85736775 |
| 89 | MP0005253_abnormal_eye_physiology | 0.85246287 |
| 90 | MP0004883_abnormal_blood_vessel | 0.84262647 |
| 91 | MP0003632_abnormal_nervous_system | 0.84248263 |
| 92 | MP0000462_abnormal_digestive_system | 0.83278982 |
| 93 | MP0001346_abnormal_lacrimal_gland | 0.80838882 |
| 94 | MP0003385_abnormal_body_wall | 0.80117999 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.79058655 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.78763566 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.78757803 |
| 98 | MP0002254_reproductive_system_inflammat | 0.78475021 |
| 99 | MP0003938_abnormal_ear_development | 0.77273879 |
| 100 | MP0009053_abnormal_anal_canal | 0.75876344 |
| 101 | MP0008260_abnormal_autophagy | 0.74908219 |
| 102 | MP0003786_premature_aging | 0.74458365 |
| 103 | MP0001542_abnormal_bone_strength | 0.74430250 |
| 104 | MP0002009_preneoplasia | 0.74006690 |
| 105 | MP0004885_abnormal_endolymph | 0.73131551 |
| 106 | MP0005448_abnormal_energy_balance | 0.71899656 |
| 107 | MP0003634_abnormal_glial_cell | 0.70246242 |
| 108 | MP0004130_abnormal_muscle_cell | 0.70159097 |
| 109 | MP0002098_abnormal_vibrissa_morphology | 0.69717964 |
| 110 | MP0001943_abnormal_respiration | 0.67931705 |
| 111 | MP0002082_postnatal_lethality | 0.67105013 |
| 112 | MP0010770_preweaning_lethality | 0.67105013 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.66937834 |
| 114 | MP0001177_atelectasis | 0.66551944 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.64734865 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.63839515 |
| 117 | MP0010769_abnormal_survival | 0.63252202 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62743347 |
| 119 | MP0005535_abnormal_body_temperature | 0.62575946 |
| 120 | MP0002163_abnormal_gland_morphology | 0.61799104 |
| 121 | MP0002928_abnormal_bile_duct | 0.61536239 |
| 122 | MP0000538_abnormal_urinary_bladder | 0.60697856 |
| 123 | MP0000604_amyloidosis | 0.60621283 |
| 124 | MP0004484_altered_response_of | 0.60238194 |
| 125 | MP0010768_mortality/aging | 0.58618592 |
| 126 | MP0000534_abnormal_ureter_morphology | 0.58254055 |
| 127 | MP0005266_abnormal_metabolism | 0.57930265 |
| 128 | MP0002081_perinatal_lethality | 0.57828600 |
| 129 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57629369 |
| 130 | MP0003690_abnormal_glial_cell | 0.57274493 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.56886664 |
| 132 | MP0002822_catalepsy | 0.55849567 |
| 133 | MP0004272_abnormal_basement_membrane | 0.55735801 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.55460563 |
| 135 | MP0001986_abnormal_taste_sensitivity | 0.55194265 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.54710722 |
| 137 | MP0008770_decreased_survivor_rate | 0.53940095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atonic seizures (HP:0010819) | 6.02368673 |
| 2 | Hand muscle atrophy (HP:0009130) | 5.51115071 |
| 3 | Carpal bone hypoplasia (HP:0001498) | 5.34748659 |
| 4 | Aplasia of the musculature (HP:0100854) | 5.33576581 |
| 5 | Hip dysplasia (HP:0001385) | 5.25716457 |
| 6 | Fetal akinesia sequence (HP:0001989) | 5.09113687 |
| 7 | Hip contracture (HP:0003273) | 4.99058255 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.82642021 |
| 9 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.82511299 |
| 10 | Barrel-shaped chest (HP:0001552) | 4.56878899 |
| 11 | Absence seizures (HP:0002121) | 4.50057033 |
| 12 | Spinal muscular atrophy (HP:0007269) | 4.43793571 |
| 13 | Focal seizures (HP:0007359) | 4.38627657 |
| 14 | Diaphragmatic weakness (HP:0009113) | 4.23755146 |
| 15 | Sleep apnea (HP:0010535) | 4.20670204 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 4.09915680 |
| 17 | Distal upper limb amyotrophy (HP:0007149) | 4.08804889 |
| 18 | Upper limb amyotrophy (HP:0009129) | 4.08804889 |
| 19 | Stridor (HP:0010307) | 3.99825464 |
| 20 | Dialeptic seizures (HP:0011146) | 3.96883934 |
| 21 | Febrile seizures (HP:0002373) | 3.96128993 |
| 22 | Myokymia (HP:0002411) | 3.84719288 |
| 23 | Down-sloping shoulders (HP:0200021) | 3.75053690 |
| 24 | Abnormality of the vocal cords (HP:0008777) | 3.71295313 |
| 25 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.66597916 |
| 26 | Flat acetabular roof (HP:0003180) | 3.60230263 |
| 27 | Polyphagia (HP:0002591) | 3.53595058 |
| 28 | Obstructive sleep apnea (HP:0002870) | 3.46237286 |
| 29 | Limited hip movement (HP:0008800) | 3.44984520 |
| 30 | Limb-girdle muscle atrophy (HP:0003797) | 3.35962063 |
| 31 | Focal motor seizures (HP:0011153) | 3.34574742 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 3.33052524 |
| 33 | Postural tremor (HP:0002174) | 3.31987350 |
| 34 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.31810172 |
| 35 | Nonprogressive disorder (HP:0003680) | 3.29263247 |
| 36 | Mutism (HP:0002300) | 3.27251327 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 3.23769459 |
| 38 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.22224516 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 3.20954920 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 3.20290367 |
| 41 | Limb dystonia (HP:0002451) | 3.20076100 |
| 42 | Truncal ataxia (HP:0002078) | 3.19316424 |
| 43 | Neurofibrillary tangles (HP:0002185) | 3.18493450 |
| 44 | Broad-based gait (HP:0002136) | 3.14791575 |
| 45 | Severe visual impairment (HP:0001141) | 3.12337787 |
| 46 | Disproportionate short-trunk short stature (HP:0003521) | 3.10745278 |
| 47 | Drooling (HP:0002307) | 3.08019505 |
| 48 | Excessive salivation (HP:0003781) | 3.08019505 |
| 49 | Small hand (HP:0200055) | 3.05357290 |
| 50 | Hemiparesis (HP:0001269) | 3.02003735 |
| 51 | Cortical dysplasia (HP:0002539) | 3.00716462 |
| 52 | Abdominal situs inversus (HP:0003363) | 2.92356081 |
| 53 | Abnormality of abdominal situs (HP:0011620) | 2.92356081 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.91506559 |
| 55 | Amblyopia (HP:0000646) | 2.90834132 |
| 56 | Metaphyseal irregularity (HP:0003025) | 2.81789029 |
| 57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.81146679 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.81146679 |
| 59 | Hyperalaninemia (HP:0003348) | 2.81146679 |
| 60 | Midline defect of the nose (HP:0004122) | 2.79068938 |
| 61 | True hermaphroditism (HP:0010459) | 2.77987109 |
| 62 | Ankle clonus (HP:0011448) | 2.74972642 |
| 63 | Hypoplasia of the odontoid process (HP:0003311) | 2.73871489 |
| 64 | Abnormality of the labia minora (HP:0012880) | 2.70128645 |
| 65 | Difficulty running (HP:0009046) | 2.68843774 |
| 66 | Knee flexion contracture (HP:0006380) | 2.67920591 |
| 67 | Exotropia (HP:0000577) | 2.67037174 |
| 68 | Supernumerary spleens (HP:0009799) | 2.66486453 |
| 69 | Progressive inability to walk (HP:0002505) | 2.64065262 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.60089693 |
| 71 | Epiphyseal dysplasia (HP:0002656) | 2.58243836 |
| 72 | Scapular winging (HP:0003691) | 2.57553171 |
| 73 | Pancreatic cysts (HP:0001737) | 2.54063532 |
| 74 | Inappropriate behavior (HP:0000719) | 2.51814842 |
| 75 | Esotropia (HP:0000565) | 2.50636077 |
| 76 | Urinary urgency (HP:0000012) | 2.49683062 |
| 77 | Spinal cord compression (HP:0002176) | 2.49378937 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.47779444 |
| 79 | Torticollis (HP:0000473) | 2.46918496 |
| 80 | Nuclear cataract (HP:0100018) | 2.43991360 |
| 81 | Anxiety (HP:0000739) | 2.43017214 |
| 82 | Agitation (HP:0000713) | 2.42377709 |
| 83 | Abnormal pupillary function (HP:0007686) | 2.40720926 |
| 84 | Anencephaly (HP:0002323) | 2.40506338 |
| 85 | Scanning speech (HP:0002168) | 2.39009687 |
| 86 | Failure to thrive in infancy (HP:0001531) | 2.38423562 |
| 87 | Shoulder girdle muscle weakness (HP:0003547) | 2.37693319 |
| 88 | Visual hallucinations (HP:0002367) | 2.36355940 |
| 89 | Lower limb asymmetry (HP:0100559) | 2.32779559 |
| 90 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30626394 |
| 91 | Progressive macrocephaly (HP:0004481) | 2.29079580 |
| 92 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.28166573 |
| 93 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28007521 |
| 94 | Abnormality of the intervertebral disk (HP:0005108) | 2.25170132 |
| 95 | Morphological abnormality of the middle ear (HP:0008609) | 2.24607132 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.23659336 |
| 97 | Abnormality of the odontoid process (HP:0003310) | 2.23137115 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.22624292 |
| 99 | Abnormal eating behavior (HP:0100738) | 2.21186681 |
| 100 | Termporal pattern (HP:0011008) | 2.19139280 |
| 101 | Insidious onset (HP:0003587) | 2.19139280 |
| 102 | Akinesia (HP:0002304) | 2.19032173 |
| 103 | Facial hemangioma (HP:0000329) | 2.18119909 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 2.16032369 |
| 105 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.15529215 |
| 106 | Dysmetria (HP:0001310) | 2.15476476 |
| 107 | Hypoparathyroidism (HP:0000829) | 2.14342574 |
| 108 | Abnormality of the musculature of the hand (HP:0001421) | 2.14101090 |
| 109 | Sex reversal (HP:0012245) | 2.13894361 |
| 110 | Abnormal sex determination (HP:0012244) | 2.13894361 |
| 111 | Status epilepticus (HP:0002133) | 2.11959768 |
| 112 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.10430169 |
| 113 | Hypoplasia of the brainstem (HP:0002365) | 2.10430169 |
| 114 | Abnormality of secondary sexual hair (HP:0009888) | 2.10185058 |
| 115 | Abnormality of the axillary hair (HP:0100134) | 2.10185058 |
| 116 | Inability to walk (HP:0002540) | 2.09964402 |
| 117 | Short femoral neck (HP:0100864) | 2.09850651 |
| 118 | Short tibia (HP:0005736) | 2.09744248 |
| 119 | Sparse lateral eyebrow (HP:0005338) | 2.09594505 |
| 120 | Molar tooth sign on MRI (HP:0002419) | 2.08970994 |
| 121 | Abnormality of midbrain morphology (HP:0002418) | 2.08970994 |
| 122 | Protruding tongue (HP:0010808) | 2.08434252 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07912228 |
| 124 | Horizontal nystagmus (HP:0000666) | 2.07891623 |
| 125 | High anterior hairline (HP:0009890) | 2.07315459 |
| 126 | Abnormality of the parathyroid morphology (HP:0011766) | 2.06111915 |
| 127 | Generalized myoclonic seizures (HP:0002123) | 2.05518598 |
| 128 | Hypsarrhythmia (HP:0002521) | 2.03306599 |
| 129 | Long foot (HP:0001833) | 2.02919547 |
| 130 | Abnormal number of incisors (HP:0011064) | 2.00449181 |
| 131 | Humeroradial synostosis (HP:0003041) | 2.00385952 |
| 132 | Synostosis involving the elbow (HP:0003938) | 2.00385952 |
| 133 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.00174529 |
| 134 | Epileptiform EEG discharges (HP:0011182) | 1.99072624 |
| 135 | Reticulocytopenia (HP:0001896) | 1.98897495 |
| 136 | Hypothermia (HP:0002045) | 1.98455161 |
| 137 | Epidermoid cyst (HP:0200040) | 1.97486364 |
| 138 | Action tremor (HP:0002345) | 1.96968132 |
| 139 | Gowers sign (HP:0003391) | 1.96706101 |
| 140 | Optic disc pallor (HP:0000543) | 1.95473044 |
| 141 | Cystic liver disease (HP:0006706) | 1.94783792 |
| 142 | Apathy (HP:0000741) | 1.94749841 |
| 143 | Abnormality of salivation (HP:0100755) | 1.94106076 |
| 144 | Diplopia (HP:0000651) | 1.93430143 |
| 145 | Abnormality of binocular vision (HP:0011514) | 1.93430143 |
| 146 | Papillary thyroid carcinoma (HP:0002895) | 1.93319506 |
| 147 | Psychosis (HP:0000709) | 1.91972015 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.91590932 |
| 149 | Hepatoblastoma (HP:0002884) | 1.90870094 |
| 150 | Epileptic encephalopathy (HP:0200134) | 1.90619011 |
| 151 | Abnormal vertebral ossification (HP:0100569) | 1.88203949 |
| 152 | Intellectual disability, moderate (HP:0002342) | 1.87814971 |
| 153 | Acute encephalopathy (HP:0006846) | 1.87503130 |
| 154 | Open mouth (HP:0000194) | 1.87333262 |
| 155 | Heterochromia iridis (HP:0001100) | 1.85775935 |
| 156 | Alacrima (HP:0000522) | 1.85069055 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.84588227 |
| 158 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.83790227 |
| 159 | Absent septum pellucidum (HP:0001331) | 1.83722944 |
| 160 | Spastic gait (HP:0002064) | 1.83679893 |
| 161 | Sacral dimple (HP:0000960) | 1.83005515 |
| 162 | Abnormality of the pubic bones (HP:0003172) | 1.82330004 |
| 163 | Pheochromocytoma (HP:0002666) | 1.82272778 |
| 164 | Hyperventilation (HP:0002883) | 1.82080916 |
| 165 | Testicular neoplasm (HP:0010788) | 1.81681382 |
| 166 | Macroorchidism (HP:0000053) | 1.81517764 |
| 167 | Lower limb amyotrophy (HP:0007210) | 1.81448268 |
| 168 | Impaired social interactions (HP:0000735) | 1.81049494 |
| 169 | Preaxial hand polydactyly (HP:0001177) | 1.80681484 |
| 170 | Achilles tendon contracture (HP:0001771) | 1.79601169 |
| 171 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79461510 |
| 172 | Sclerocornea (HP:0000647) | 1.78380200 |
| 173 | Abnormality of carpal bone ossification (HP:0006257) | 1.77260585 |
| 174 | Craniofacial dystonia (HP:0012179) | 1.77241547 |
| 175 | Lissencephaly (HP:0001339) | 1.73571280 |
| 176 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.72537993 |
| 177 | Intestinal atresia (HP:0011100) | 1.71963745 |
| 178 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71697894 |
| 179 | Gastrointestinal atresia (HP:0002589) | 1.70010869 |
| 180 | Esophageal atresia (HP:0002032) | 1.68292371 |
| 181 | Nephronophthisis (HP:0000090) | 1.68060742 |
| 182 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.67333906 |
| 183 | Absent toe (HP:0010760) | 1.66342383 |
| 184 | Abnormal hand bone ossification (HP:0010660) | 1.66151252 |
| 185 | Oculomotor apraxia (HP:0000657) | 1.64469183 |
| 186 | Genu varum (HP:0002970) | 1.62491969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.95814756 |
| 2 | GRK7 | 4.34850320 |
| 3 | MAP4K2 | 3.89072303 |
| 4 | NTRK2 | 3.78179367 |
| 5 | FRK | 3.61986647 |
| 6 | MAP3K9 | 3.60946004 |
| 7 | NTRK3 | 3.58869491 |
| 8 | CASK | 3.24446837 |
| 9 | MAPK13 | 2.91458568 |
| 10 | EPHA3 | 2.45107338 |
| 11 | PHKG2 | 2.43782562 |
| 12 | PHKG1 | 2.43782562 |
| 13 | RPS6KA4 | 2.37240624 |
| 14 | MAP3K7 | 2.36133347 |
| 15 | TAOK1 | 2.31314835 |
| 16 | DYRK2 | 2.21968421 |
| 17 | TNIK | 2.16344195 |
| 18 | TAOK3 | 2.01334461 |
| 19 | CDK8 | 2.00244362 |
| 20 | ACVR1B | 1.98370704 |
| 21 | UHMK1 | 1.98138772 |
| 22 | NME1 | 1.92199453 |
| 23 | KSR1 | 1.87647996 |
| 24 | MAP3K4 | 1.83001677 |
| 25 | LATS2 | 1.81755931 |
| 26 | IRAK1 | 1.72187876 |
| 27 | CLK1 | 1.69442480 |
| 28 | MINK1 | 1.66217963 |
| 29 | MAPK15 | 1.63554676 |
| 30 | EPHB1 | 1.59787731 |
| 31 | INSRR | 1.58218692 |
| 32 | PNCK | 1.52831090 |
| 33 | SIK2 | 1.52516257 |
| 34 | ICK | 1.46358606 |
| 35 | MAPKAPK5 | 1.36549526 |
| 36 | ERBB3 | 1.36429268 |
| 37 | PLK4 | 1.31422880 |
| 38 | MAP2K7 | 1.28980930 |
| 39 | WNK3 | 1.28848885 |
| 40 | EPHA4 | 1.28441625 |
| 41 | RPS6KA5 | 1.26803968 |
| 42 | ADRBK1 | 1.25260250 |
| 43 | DAPK2 | 1.23815340 |
| 44 | MAP2K4 | 1.22873815 |
| 45 | TRIM28 | 1.21790306 |
| 46 | FGR | 1.19454027 |
| 47 | CDK3 | 1.18333664 |
| 48 | GRK5 | 1.17315416 |
| 49 | FER | 1.15776073 |
| 50 | PDK2 | 1.13949748 |
| 51 | MAP3K11 | 1.13916843 |
| 52 | BRD4 | 1.10055336 |
| 53 | CDK5 | 1.06862413 |
| 54 | EPHB2 | 1.05854592 |
| 55 | LIMK1 | 1.02516372 |
| 56 | DYRK1A | 1.01357039 |
| 57 | STK39 | 0.98846108 |
| 58 | FGFR2 | 0.97843822 |
| 59 | CSNK1G2 | 0.95999573 |
| 60 | CAMK1G | 0.95308506 |
| 61 | TYRO3 | 0.92932702 |
| 62 | PAK3 | 0.92844191 |
| 63 | MAPK12 | 0.88779208 |
| 64 | WNK4 | 0.88761836 |
| 65 | BMPR1B | 0.87448901 |
| 66 | CAMK2A | 0.86561747 |
| 67 | CDK19 | 0.84470578 |
| 68 | RIPK1 | 0.82028276 |
| 69 | CAMK2B | 0.80796279 |
| 70 | CSNK1G3 | 0.78656296 |
| 71 | GRK6 | 0.77881427 |
| 72 | CDK14 | 0.76723850 |
| 73 | STK11 | 0.76540002 |
| 74 | CAMK1D | 0.75883363 |
| 75 | IRAK2 | 0.75448300 |
| 76 | BCR | 0.74185008 |
| 77 | FES | 0.72954477 |
| 78 | KSR2 | 0.72861674 |
| 79 | CDK18 | 0.71647498 |
| 80 | CDK15 | 0.71640902 |
| 81 | MAP3K2 | 0.69013821 |
| 82 | PRKD3 | 0.68316256 |
| 83 | PLK2 | 0.68067355 |
| 84 | TSSK6 | 0.67923303 |
| 85 | CSNK1A1L | 0.65323494 |
| 86 | CDK11A | 0.64949107 |
| 87 | TLK1 | 0.64846516 |
| 88 | PRKCG | 0.64148059 |
| 89 | PAK6 | 0.63272636 |
| 90 | CCNB1 | 0.62005887 |
| 91 | LMTK2 | 0.61412151 |
| 92 | MAP3K12 | 0.60939539 |
| 93 | ADRBK2 | 0.60306591 |
| 94 | MAPK4 | 0.58887264 |
| 95 | PKN1 | 0.58782518 |
| 96 | SRPK1 | 0.58200083 |
| 97 | PRKCZ | 0.56726533 |
| 98 | MKNK2 | 0.55176693 |
| 99 | NTRK1 | 0.53866694 |
| 100 | GRK1 | 0.51568195 |
| 101 | SIK1 | 0.50652100 |
| 102 | CSNK1G1 | 0.49933246 |
| 103 | MAPK9 | 0.48420705 |
| 104 | AKT3 | 0.48139625 |
| 105 | CAMK4 | 0.47820010 |
| 106 | WEE1 | 0.47599917 |
| 107 | DAPK1 | 0.46995702 |
| 108 | BRSK2 | 0.46682698 |
| 109 | TAOK2 | 0.46593449 |
| 110 | ZAK | 0.46032607 |
| 111 | PRKG1 | 0.45492185 |
| 112 | MARK2 | 0.45104769 |
| 113 | PRKCE | 0.44280254 |
| 114 | STK38 | 0.44158362 |
| 115 | TGFBR1 | 0.43791423 |
| 116 | ERBB2 | 0.43054273 |
| 117 | MKNK1 | 0.42472811 |
| 118 | ERBB4 | 0.41944360 |
| 119 | PRKACA | 0.41937505 |
| 120 | CAMK1 | 0.41772030 |
| 121 | PRKAA2 | 0.39039474 |
| 122 | CAMK2G | 0.38481302 |
| 123 | PRKCB | 0.37005173 |
| 124 | DYRK1B | 0.36681631 |
| 125 | OXSR1 | 0.36622139 |
| 126 | ARAF | 0.36492909 |
| 127 | PRKAA1 | 0.36176256 |
| 128 | NUAK1 | 0.35997746 |
| 129 | PRKACG | 0.35272516 |
| 130 | CSNK1D | 0.34555505 |
| 131 | MAP3K10 | 0.34523290 |
| 132 | DYRK3 | 0.33945152 |
| 133 | CSNK1E | 0.33000603 |
| 134 | RET | 0.32361538 |
| 135 | ALK | 0.32227562 |
| 136 | STK4 | 0.31214077 |
| 137 | LYN | 0.30165719 |
| 138 | SGK1 | 0.29934891 |
| 139 | GSK3A | 0.29806672 |
| 140 | PRKCA | 0.29622303 |
| 141 | GSK3B | 0.29463772 |
| 142 | CDK1 | 0.29456704 |
| 143 | SGK494 | 0.29267445 |
| 144 | SGK223 | 0.29267445 |
| 145 | ROCK2 | 0.28991332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.63428664 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.00285337 |
| 3 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.67553651 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66011225 |
| 5 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.59232115 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.57987241 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45021310 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.43751011 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35427776 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.11584888 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.05219593 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.95220976 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93134516 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.90766581 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87045025 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.85833173 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.85492783 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.78225256 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.77469061 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.76830761 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76727741 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76507512 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74096519 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.69865244 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.62904436 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.60066438 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.57173381 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.53875654 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51662773 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50886613 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.48719883 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.48300202 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42554957 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33376690 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33169488 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.28173483 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.27050120 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25966618 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.25070503 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24602019 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23122641 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.22571784 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22111274 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21265539 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.19871678 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18331885 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16282004 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15902766 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14441636 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14288714 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12148894 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.11453075 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10312621 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09616763 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08803881 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08414629 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08105201 |
| 58 | Protein export_Homo sapiens_hsa03060 | 1.06678408 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06306216 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05998451 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03287402 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.99535050 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96771032 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96736917 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96667188 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94893898 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93892496 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91735657 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90717127 |
| 70 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90197344 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86702187 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85869745 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83830166 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.78836955 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.77899881 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77717712 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76125714 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76060824 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 0.75457843 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74459755 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72172323 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68074597 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67302879 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66967922 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.66360378 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66282393 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65114574 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64695931 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63960388 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63810786 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63538137 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61865416 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58632147 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57485860 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55240797 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54021528 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53855571 |
| 98 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53193580 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53141474 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52888620 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51849604 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51523223 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51127266 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50002988 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.49330461 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47952185 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.47431936 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46821609 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.46597772 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44999544 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44724875 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.40962818 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39828533 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39527742 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38857143 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38135218 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36520100 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36372681 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35718555 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34973160 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34779752 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34094412 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.33938445 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33541659 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33437768 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33199033 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33189385 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32785887 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31849680 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.31699743 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30783627 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29438415 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29309549 |
| 134 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28886565 |
| 135 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28727112 |
| 136 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28057343 |
| 137 | Phototransduction_Homo sapiens_hsa04744 | 0.27568821 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.26385360 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26219281 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26013262 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.25059203 |
| 142 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24820684 |

